187 related articles for article (PubMed ID: 38050474)
21. Iridium(III) Complex-Loaded Perfluoropropane Nanobubbles for Enhanced Sonodynamic Therapy.
Nittayacharn P; Abenojar E; La Deda M; Ricciardi L; Strangi G; Exner AA
Bioconjug Chem; 2022 Jun; 33(6):1057-1068. PubMed ID: 33677967
[TBL] [Abstract][Full Text] [Related]
22. Acetylshikonin Sensitizes Hepatocellular Carcinoma Cells to Apoptosis through ROS-Mediated Caspase Activation.
Hong M; Li J; Li S; M Almutairi M
Cells; 2019 Nov; 8(11):. PubMed ID: 31752383
[TBL] [Abstract][Full Text] [Related]
23. Iron oxide nanoparticles as nanocarriers to improve chlorin e6-based sonosensitivity in sonodynamic therapy.
Zhang P; Ren Z; Chen Z; Zhu J; Liang J; Liao R; Wen J
Drug Des Devel Ther; 2018; 12():4207-4216. PubMed ID: 30573951
[TBL] [Abstract][Full Text] [Related]
24. Extracellular signal-regulated kinase, receptor interacting protein, and reactive oxygen species regulate shikonin-induced autophagy in human hepatocellular carcinoma.
Gong K; Zhang Z; Chen Y; Shu HB; Li W
Eur J Pharmacol; 2014 Sep; 738():142-52. PubMed ID: 24886888
[TBL] [Abstract][Full Text] [Related]
25. Shikonin-induced necroptosis is enhanced by the inhibition of autophagy in non-small cell lung cancer cells.
Kim HJ; Hwang KE; Park DS; Oh SH; Jun HY; Yoon KH; Jeong ET; Kim HR; Kim YS
J Transl Med; 2017 May; 15(1):123. PubMed ID: 28569199
[TBL] [Abstract][Full Text] [Related]
26. Shikonin induces glioma cell necroptosis in vitro by ROS overproduction and promoting RIP1/RIP3 necrosome formation.
Lu B; Gong X; Wang ZQ; Ding Y; Wang C; Luo TF; Piao MH; Meng FK; Chi GF; Luo YN; Ge PF
Acta Pharmacol Sin; 2017 Nov; 38(11):1543-1553. PubMed ID: 28816233
[TBL] [Abstract][Full Text] [Related]
27. Shikonin suppresses progression and epithelial-mesenchymal transition in hepatocellular carcinoma (HCC) cells by modulating miR-106b/SMAD7/TGF-β signaling pathway.
Li X; Zeng X
Cell Biol Int; 2020 Feb; 44(2):467-476. PubMed ID: 31617643
[TBL] [Abstract][Full Text] [Related]
28. Nanobubbles Containing sPD-1 and Ce6 Mediate Combination Immunotherapy and Suppress Hepatocellular Carcinoma in Mice.
Tan Y; Yang S; Ma Y; Li J; Xie Q; Liu C; Zhao Y
Int J Nanomedicine; 2021; 16():3241-3254. PubMed ID: 34007176
[TBL] [Abstract][Full Text] [Related]
29. Hyperthermotherapy enhances antitumor effect of 5-aminolevulinic acid-mediated sonodynamic therapy with activation of caspase-dependent apoptotic pathway in human glioma.
Ju D; Yamaguchi F; Zhan G; Higuchi T; Asakura T; Morita A; Orimo H; Hu S
Tumour Biol; 2016 Aug; 37(8):10415-26. PubMed ID: 26846106
[TBL] [Abstract][Full Text] [Related]
30. Gene augmented nuclear-targeting sonodynamic therapy via Nrf2 pathway-based redox balance adjustment boosts peptide-based anti-PD-L1 therapy on colorectal cancer.
Wan G; Chen X; Wang H; Hou S; Wang Q; Cheng Y; Chen Q; Lv Y; Chen H; Zhang Q
J Nanobiotechnology; 2021 Oct; 19(1):347. PubMed ID: 34715867
[TBL] [Abstract][Full Text] [Related]
31. RIP1K and RIP3K provoked by shikonin induce cell cycle arrest in the triple negative breast cancer cell line, MDA-MB-468: necroptosis as a desperate programmed suicide pathway.
Shahsavari Z; Karami-Tehrani F; Salami S; Ghasemzadeh M
Tumour Biol; 2016 Apr; 37(4):4479-91. PubMed ID: 26496737
[TBL] [Abstract][Full Text] [Related]
32. Shikonin differentially regulates glucose metabolism via PKM2 and HIF1α to overcome apoptosis in a refractory HCC cell line.
Yang W; Liu J; Hou L; Chen Q; Liu Y
Life Sci; 2021 Jan; 265():118796. PubMed ID: 33220292
[TBL] [Abstract][Full Text] [Related]
33. Targeting Cell Necroptosis and Apoptosis Induced by Shikonin via Receptor Interacting Protein Kinases in Estrogen Receptor Positive Breast Cancer Cell Line, MCF-7.
Shahsavari Z; Karami-Tehrani F; Salami S
Anticancer Agents Med Chem; 2018; 18(2):245-254. PubMed ID: 28933271
[TBL] [Abstract][Full Text] [Related]
34. Shikonin potentiates the effect of arsenic trioxide against human hepatocellular carcinoma in vitro and in vivo.
Song J; Zhao Z; Fan X; Chen M; Cheng X; Zhang D; Wu F; Ying X; Ji J
Oncotarget; 2016 Oct; 7(43):70504-70515. PubMed ID: 27655700
[TBL] [Abstract][Full Text] [Related]
35. Sonodynamic therapy-based nanoplatforms for combating bacterial infections.
Xu PY; Kumar Kankala R; Wang SB; Chen AZ
Ultrason Sonochem; 2023 Nov; 100():106617. PubMed ID: 37769588
[TBL] [Abstract][Full Text] [Related]
36. Necroptosis-Inducible Polymeric Nanobubbles for Enhanced Cancer Sonoimmunotherapy.
Um W; Ko H; You DG; Lim S; Kwak G; Shim MK; Yang S; Lee J; Song Y; Kim K; Park JH
Adv Mater; 2020 Apr; 32(16):e1907953. PubMed ID: 32125731
[TBL] [Abstract][Full Text] [Related]
37. Engineered extracellular vesicle-based sonotheranostics for dual stimuli-sensitive drug release and photoacoustic imaging-guided chemo-sonodynamic cancer therapy.
Nguyen Cao TG; Kang JH; Kim W; Lim J; Kang SJ; You JY; Truong Hoang Q; Kim WJ; Rhee WJ; Kim C; Ko YT; Shim MS
Theranostics; 2022; 12(3):1247-1266. PubMed ID: 35154485
[TBL] [Abstract][Full Text] [Related]
38. Targeted Nanobubbles of PD-L1 mAb Combined with Doxorubicin as a Synergistic Tumor Repressor in Hepatocarcinoma.
Chen Y; Luo X; Liu Y; Zou Y; Yang S; Liu C; Zhao Y
Int J Nanomedicine; 2022; 17():3989-4008. PubMed ID: 36105615
[TBL] [Abstract][Full Text] [Related]
39. Shikonin-induced necroptosis in nasopharyngeal carcinoma cells via ROS overproduction and upregulation of RIPK1/RIPK3/MLKL expression.
Liu T; Sun X; Cao Z
Onco Targets Ther; 2019; 12():2605-2614. PubMed ID: 31118661
[No Abstract] [Full Text] [Related]
40. Silencing of TRAF5 enhances necroptosis in hepatocellular carcinoma by inhibiting LTBR-mediated NF-κB signaling.
Wu G; Wu F; Zhou YQ; Lu W; Hu FL; Fan X
PeerJ; 2023; 11():e15551. PubMed ID: 37366426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
